Electrochemotherapy in non-satisfactory responding tumors in vet patients: Combined administration of bleomycin, systemic and local
Electrochemotherapy (ECT), a medical treatment widely used in human tumor treatment, consists in the administration of bleomycin either systemically or locally followed by the application of an electric field. This procedure increases the toxicity of the bleomycin by 1000 fold in the treated area wi...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | , , , , , |
| Formato: | Acta de conferencia Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
Springer Verlag
2016
|
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 07094caa a22007337a 4500 | ||
|---|---|---|---|
| 001 | PAPER-24568 | ||
| 003 | AR-BaUEN | ||
| 005 | 20250625082619.0 | ||
| 008 | 190411s2016 xx ||||fo|||| 10| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-84946011161 | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 100 | 1 | |a Maglietti, F. | |
| 245 | 1 | 0 | |a Electrochemotherapy in non-satisfactory responding tumors in vet patients: Combined administration of bleomycin, systemic and local |
| 260 | |b Springer Verlag |c 2016 | ||
| 270 | 1 | 0 | |m Maglietti, F.; Laboratorio de Sistemas Complejos, Departamento de Computación e Instituto de Física del Plasma, Universidad de Buenos Aires, Intendente Güiraldes 2160, Argentina |
| 504 | |a Yarmush, M.L., Golberg, A., Sersa, G., Kotnikv, T., Miklavcic, D., Electroporation-based technologies for medicine: Principles, applications, and challenges (2014) Annual Review of Biomedical Engineering, 16, pp. 295-320 | ||
| 504 | |a Sersa, G., Garbay, J.R., Gehl, J., Collins, C., Snoj, M., Electrochemotherapy - a simple, highly effective and safe treatment of cutaneous and subcutaneous metastases: Results of ESOPE (European Standard Operating Procedures for Electrochemotherapy) study. 11 (2006) Eur J Cancer Supp, 4, pp. 3-13 | ||
| 504 | |a Mali, B., Jarm, T., Snoj, M., Sersa, G., Miklavcic, D., Antitumor effectiveness of electrochemotherapy: A systematic review and metaanalysis (2013) Eur J Sur Oncol, 39, pp. 4-16 | ||
| 504 | |a Kumar, V., Abbas, A., Neoplasia, A.J., Robbins Basic Pathology (2013) Philadelphia: Elsevier, 5, pp. 191-192 | ||
| 504 | |a Tozon, N., Cemazar, M., Electrochemotherapy in veterinary medicine (2007) IFMBE Proceedings, 16, pp. 586-588 | ||
| 504 | |a Spugnini, E.P., Baldi, F., Mellone, P., Feroce, F., D'avino, A., Bonetto, F., Vincenzi, B., Baldi, A., Patterns of tumor response in canine and feline cancer patients treated with electrochemotherapy: Preclinical data for the standardization of this treatment in pets and humans (2007) Journal of Translational Medicine, 5 (48) | ||
| 504 | |a London, C.A., (2010) Cancer Research, , Spontaneous cancer in dogs: Opportunities for preclinical evaluation of novel therapies. Clinical Cancer Research | ||
| 504 | |a Vail, D.M., Macewen, E.G., Spontaneously Occurring Tumors of Companion Animals as Models for Human Cancer. 18 (2000) Cancer Invest, 8, pp. 781-792 | ||
| 504 | |a Mir, L., Gehl, J., Sersa, G., Collins, C., Garbay, J.M., Billard, V., Geertsen, P., Marty, M., Standard operating procedures of the electrochemotherapy: Instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator by means of invasive or non-invasive electrodes (2006) Eur J Cancer Supp, 4, pp. 14-25 | ||
| 504 | |a (1979) WHO Handbook for Reporting Results of Cancer Treatment, , Geneva: WHO | ||
| 504 | |a Jaroszeski, M.J., Gilbert, R., Perrott, R., Heller, R., Enhanced effects of multiple treatment electrochemotherapy (1996) Melanoma Research, 6, pp. 427-433A4 - Elea Vertriebs- und Vermarktungsgesellschaft mbH; Electroblate, Inc.; Etal; IGEA S.p.A.; Inovio Pharmaceuticals, Inc.; OncoSec Medical, Inc. | ||
| 506 | |2 openaire |e Política editorial | ||
| 520 | 3 | |a Electrochemotherapy (ECT), a medical treatment widely used in human tumor treatment, consists in the administration of bleomycin either systemically or locally followed by the application of an electric field. This procedure increases the toxicity of the bleomycin by 1000 fold in the treated area with an objective response rate of around 80%. Despite its success related to efficiency, low cost and minimum side effects, there is still a 20% of cases in which the ECT treatment is not responding. This could be ascribed to the fact that bleomycin, administered in the preferred way, that is, systemically for large tumors, is not properly reaching the whole tumor mass. The main cause is poor tumor vascularization, in which case local administration could cover areas unreachable with systemic administration. To address this problem here we propose the combined administration of bleomycin, systemic and locally, using companion animals as models for ECT tumor treating. Accordingly, we selected 7 canine and 2 feline patients with a single tumor with poor or no response to ECT, and then we repeat the treatment with ECT but now with a combined administration of bleomycin, systemic and local. The results show, according to an evaluation using the WHO criteria of tumor response, that from the 9 cases, 5 achieved a Complete Response, 3 a Partial Response, and 1 a Stable Disease after 30 days from the combined treatment date. In conclusion, the combined administration of bleomycin, systemic and local, in ECT could provide a good response in tumors that previously showed an unsatisfactory response. It is expected that these results could hopefully increase ECT efficiency. © Springer Science+Business Media Singapore 2016. |l eng | |
| 593 | |a Laboratorio de Sistemas Complejos, Dpto de Computación e Instituto de Física del Plasma, Universidad de Buenos Aires, Buenos Aires, Argentina | ||
| 593 | |a Consejo Nacional de Investigaciones Científicas y Técnicas, Buenos Aires, Argentina | ||
| 593 | |a Universidad de Buenos Aires, Buenos Aires, Argentina | ||
| 690 | 1 | 0 | |a BLEOMYCIN |
| 690 | 1 | 0 | |a COMBINED |
| 690 | 1 | 0 | |a ELECTROCHEMOTHERAPY |
| 690 | 1 | 0 | |a LOCAL SYSTEMIC |
| 690 | 1 | 0 | |a EFFICIENCY |
| 690 | 1 | 0 | |a ELECTRIC FIELDS |
| 690 | 1 | 0 | |a ENVIRONMENTAL TECHNOLOGY |
| 690 | 1 | 0 | |a PATIENT TREATMENT |
| 690 | 1 | 0 | |a PEPTIDES |
| 690 | 1 | 0 | |a BLEOMYCINS |
| 690 | 1 | 0 | |a COMBINED |
| 690 | 1 | 0 | |a COMBINED TREATMENT |
| 690 | 1 | 0 | |a COMPLETE RESPONSE |
| 690 | 1 | 0 | |a ELECTROCHEMOTHERAPY |
| 690 | 1 | 0 | |a LOCAL SYSTEMIC |
| 690 | 1 | 0 | |a SYSTEMIC ADMINISTRATION |
| 690 | 1 | 0 | |a TUMOR VASCULARIZATION |
| 690 | 1 | 0 | |a TUMORS |
| 700 | 1 | |a Tellado, M. | |
| 700 | 1 | |a Olaiz, N. | |
| 700 | 1 | |a Michinski, S. | |
| 700 | 1 | |a Marshall, Guillermo Ricardo | |
| 700 | 1 | |a Kramar P. | |
| 700 | 1 | |a Jarm T. | |
| 711 | 2 | |d 6 September 2015 through 10 September 2015 |g Código de la conferencia: 140699 | |
| 773 | 0 | |d Springer Verlag, 2016 |g v. 53 |h pp. 445-448 |p IFMBE Proc. |n IFMBE Proceedings |x 16800737 |z 9789812878168 |t 1st World Congress on Electroporation and Pulsed Electric Fields in Biology, Medicine and Food and Environmental Technologies, WC 2015 | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-84946011161&doi=10.1007%2f978-981-287-817-5_97&partnerID=40&md5=550785ef0c231249aed40be539b225d0 |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-981-287-817-5_97 |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_16800737_v53_n_p445_Maglietti |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_16800737_v53_n_p445_Maglietti |y Registro en la Biblioteca Digital |
| 961 | |a paper_16800737_v53_n_p445_Maglietti |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/conferenceObject |a info:ar-repo/semantics/documento de conferencia |b info:eu-repo/semantics/publishedVersion | ||
| 999 | |c 85521 | ||